You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 32 No. 12, December 1975 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (133)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Permeability Characteristics of Brain Adjacent to Tumors in Rats

Victor A. Levin, MD; Mary Freeman-Dove; Herbert D. Landahl, PhD

Arch Neurol. 1975;32(12):785-791.


Abstract



• The brain immediately surrounding 9L sarcoma and Walker 256 carcinosarcoma was evaluated, using radioactive water, albumin, red blood cells, urea, and sodium to quantitate isotopic exchange and permeability in the brain adjacent to tumor (BAT), normal brain, and, to a lesser extent, tumor. Exchange between blood and BAT for 14C-urea and 22Na averaged 53% of that for comparable regions of normal brain. This reduction in exchange is not explainable by differences in capillary surface area for transcapillary exchange in the BAT. This reduction in capillary permeability in the BAT could be detrimental to the delivery of watersoluble and rapidly binding drugs.



Author Affiliations



From the Naffziger Laboratories, Department of Neurosurgery (Dr Levin and Ms Freeman-Dove), the Department of Neurology (Dr Levin), and the Department of Biochemistry and Biophysics (Dr Landahl), the University of California at San Francisco Medical School, and the Department of Pharmaceutical Chemistry, University of California at San Francisco Pharmacy School (Dr Levin).


Footnotes



Accepted for publication Jan 13, 1975.

Read in part before the 26th Annual meeting of the American Academy of Neurology, San Francisco, April 20, 1974.

Reprint requests to Naffziger Laboratories for Neurological Research, HSW 783, University of California, San Francisco, CA 94143 (Dr Levin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Distribution of STI-571 to the Brain Is Limited by P-Glycoprotein-Mediated Efflux
Dai et al.
J. Pharmacol. Exp. Ther. 2003;304:1085-1092.
ABSTRACT | FULL TEXT  

Imaging Brain Tumors by Targeting Peptide Radiopharmaceuticals through the Blood-Brain Barrier
Kurihara and Pardridge
Cancer Res. 1999;59:6159-6163.
ABSTRACT | FULL TEXT  

Cereport(R) (RMP-7) increases carboplatin levels in brain tumors afterpretreatment with dexamethasone
Dean et al.
Neuro Oncol 1999;1:268-274.
ABSTRACT  

Chemotherapy of Brain Tumors: The "Blood-Brain Barrier" Is Not a Factor
Vick et al.
Arch Neurol 1977;34:523-526.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.